| Primary information |
|---|
| ID | 17006 |
| Uniprot ID | E1ZZF9 |
| Description | Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into- Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; |
| Organism | Camponotus floridanus |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates; Haplorrhini; Simiiformes; Catarrhini; Hominoidea (apes); Hominidae (great apes); Homininae; Homo; Homo sapiens (Human) |
| Subcellular Location | secreted |
| Developmental Stage | NA |
| Similarity | FMRFamide related peptide family |
| Tissue Specificity | Secreted in plasma. T-kinin is detected in malignant ovarian; colon and breast carcinomas; but not in benign tumors. |
| Post Translational Modification | T10 Phenylalanine amide |
| Function | Have modulatory actions at skeletal neuromuscular junctions |
| Length | 644 |
| Molecular Weight | 71 |
| Name | FMRFamide 3 |
| Sequence | GKNDLNFIRF |
| Sequence map | NA |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|